We are live on ! Find out more
Westfield Capital Management

Westfield Capital Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 49.45%
This Fund
S&P 500
This Quarter Est. Return
+12.46%
1 Year Est. Return
+49.45%
3 Year Est. Return
+148.08%
5 Year Est. Return
+180.9%
10 Year Est. Return
+972.69%
AUM
$17B
AUM Growth
+$1.34B
Cap. Flow
-$377M
Cap. Flow %
-2.22%
Top 10 Hldgs %
15.59%
Holding
389
New
43
Increased
82
Reduced
143
Closed
65

Top Buys

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$204M
2
ABBV icon
AbbVie
ABBV
+$141M
3
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
+$130M
4
CAT icon
Caterpillar
CAT
+$125M
5
JCI icon
Johnson Controls International
JCI
+$90.6M

Top Sells

Rank Stock Value
1
VPHM
VIROPHARMA INC
VPHM
+$188M
2
MRK icon
Merck
MRK
+$155M
3
AAPL icon
Apple
AAPL
+$155M
4
CTXS
Citrix Systems Inc
CTXS
+$131M
5
BFH icon
Bread Financial
BFH
+$96.8M

Sector Composition

Rank Sector Weight
1 Healthcare 18.01%
2 Industrials 15.63%
3 Consumer Discretionary 14.7%
4 Technology 8.94%
5 Communication Services 8.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EGL
301
DELISTED
Engility Holdings, Inc.
EGL
$444K ﹤0.01%
13,300
– –
MWA icon
302
Mueller Water Products
MWA
$4.25B
$440K ﹤0.01%
47,000
– –
ARII
303
DELISTED
American Railcar Industries, Inc.
ARII
$439K ﹤0.01%
9,600
– –
ACHN
304
DELISTED
Achillion Pharmaceuticals
ACHN
$435K ﹤0.01%
+131,100
New +$380K
NEU icon
305
NewMarket
NEU
$8.23B
$431K ﹤0.01%
1,290
– –
USPH icon
306
US Physical Therapy
USPH
$1.15B
$427K ﹤0.01%
12,100
– –
KO icon
307
Coca-Cola
KO
$373B
$422K ﹤0.01%
10,210
– –
MDT icon
308
Medtronic
MDT
$110B
$398K ﹤0.01%
6,934
– –
CBRL icon
309
Cracker Barrel
CBRL
$1.32B
$369K ﹤0.01%
3,350
– –
GPX
310
DELISTED
GP Strategies Corp.
GPX
$304K ﹤0.01%
10,200
– –
TRN icon
311
Trinity Industries
TRN
$2.52B
$284K ﹤0.01%
14,446
– –
EMR icon
312
Emerson Electric
EMR
$87.4B
$281K ﹤0.01%
4,000
– –
JMP
313
DELISTED
JMP Group LLC
JMP
$275K ﹤0.01%
+37,100
New +$249K
VTR icon
314
Ventas
VTR
$47.4B
$270K ﹤0.01%
4,132
– –
MMM icon
315
3M
MMM
$92.9B
$266K ﹤0.01%
2,265
– –
IPAR icon
316
Interparfums
IPAR
$3.87B
$254K ﹤0.01%
7,100
– –
DF
317
DELISTED
Dean Foods Company
DF
$254K ﹤0.01%
14,800
– –
IWP icon
318
iShares Russell Mid-Cap Growth ETF
IWP
$20.3B
$253K ﹤0.01%
+6,000
New +$243K
HNSN
319
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$252K ﹤0.01%
+14,570
New +$270K
CVX icon
320
Chevron
CVX
$371B
$250K ﹤0.01%
2,000
– –
T icon
321
AT&T
T
$161B
$237K ﹤0.01%
+8,924
New +$235K
BA icon
322
Boeing
BA
$184B
$232K ﹤0.01%
1,700
– –
BXP icon
323
Boston Properties
BXP
$11B
$221K ﹤0.01%
2,200
– –
ARAY icon
324
Accuray
ARAY
$34.5M
– –
-75,200
Closed -$555K
BC icon
325
Brunswick
BC
$5.26B
– –
-6,200
Closed -$247K
11 12
13
14 15

Similar funds

Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $23.1B AUM 21.31% 1-Year Est. Return

Westfield Capital Management's Q4 2013 Portfolio in Review

As of Q4 2013, Westfield Capital Management held 389 positions worth $17B, up 8.6% from $15.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Westfield Capital Management's Q4 2013 filing shows 43 new, 82 increased, 143 reduced and 65 closed positions. Its largest new stake was Teva Pharmaceuticals: 5,174,039 shares worth $207M. The largest sale was VIROPHARMA INC, an estimated $188M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Westfield Capital Management's largest Q4 2013 buy was Teva Pharmaceuticals: 5,174,039 shares worth $207M.
  • Westfield Capital Management added most to AbbVie in Q4 2013, an estimated $141M increase.
  • Westfield Capital Management's biggest Q4 2013 reduction was VIROPHARMA INC, cutting an estimated $188M.
  • Westfield Capital Management fully exited Citrix Systems Inc in Q4 2013, selling an estimated $131M.
  • Westfield Capital Management's ten largest holdings make up 16% of its $17B portfolio in Q4 2013.
  • Westfield Capital Management opened 43 new positions and closed 65 in Q4 2013.
  • Westfield Capital Management's portfolio value rose 8.6% quarter-over-quarter to $17B.

Based on Westfield Capital Management's 13F filing for Q4 2013, filed 7 Feb 2014.